Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Bullboard Post History

by everswann


V.TLN

Pepmoron can't read can't add !!!! LOL!!!

Pepmoron wrote this: At this stage, TLN is three years behind XL-184. This...

February 12, 2009

V.TLN

XL 184 PI data vs. 4601 PI data

http://media.corporate-ir.net/media_files/irol/12/120923/XL184EORTC-NCI...

February 12, 2009

V.TLN

XL 184

XL-184 Dosage limitation Toxicity and side effect beyond that Long-term...

February 12, 2009

V.TLN

Exelixis deal - TLN could get the same

http://ir.exelixis.com/phoenix.zhtml?c=120923&p=irol-newsArticle&ID...

February 12, 2009

V.TLN

Hope is back!!!

We need one big investor. One hedge fund. One venture fund to buy cheap...

February 12, 2009

V.TLN

Capital market not frozen... credit market is

Credit market is borrowing/lending money Capital market is stock money...

February 12, 2009

V.TLN

Biotech Rebound this year?

Right now Big Pharma are doing since they are defensive.Also doing well are...

February 12, 2009

V.TLN

RE: RE: RE: Achieving 12.6 millions market cap

Thank you Gio. We now know that Pepmoron can't read.... What can he do?

February 12, 2009

V.TLN

Achieving 12.6 millions market cap

Next level to reach is cash level or 0,375 per share or 12.6 millions...

February 11, 2009

V.TLN

Strategic value for 4601 mutated wild RAS

http://www.medpagetoday.com/HematologyOncology/ColonCancer/12218 4601 can...

February 11, 2009

V.TLN

Internal vs. External testing efficacy

Scientific publications are done by external parties, external researchers...

February 11, 2009

V.TLN

RE: RE: Investment thesis

PepmoronSo what are u saying?Sell, right?What don't u do it and tell us...

February 11, 2009

V.TLN

White Knights - FTQ - Caisse de depot

TLN is a Quebec biotech. Quebec is an interventionist jurisdiction...

February 11, 2009

V.TLN

Confidentiality and intangible assets

I am beginning to feel sorry for you.Bidder is trying to put a price for all...

February 11, 2009

V.TLN

RE: RE: RE: RE: Market timing

Pepmoron wrote this:"It's no longer a hostile takeover jerk. RIM...

February 11, 2009

V.TLN

Investment thesis

1) Cheap, very cheap6,5 millions = market cap.It gives u 3 compounds company...

February 11, 2009

V.TLN

RE: RE: Market timing

Pepmoron wrote this Strategic review was started AFTER the "expression...

February 11, 2009

V.TLN

Market timing

Pepmoron, get a education.Try researching and learning about "market...

February 11, 2009

V.TLN

RE: Hostile offer

Pepmoron post this: If the unnamed pharma of the press release is now part...

February 11, 2009

V.TLN

Being Stolen

Pepman wrote this:The interest was so high from this unknown pharma, that TLN...

February 11, 2009

USER FEEDBACK SURVEY ×

Be the voice that helps shape the content on site!

At Stockhouse, we’re committed to delivering content that matters to you. Your insights are key in shaping our strategy. Take a few minutes to share your feedback and help influence what you see on our site!

The Market Online in partnership with Stockhouse